Lotus Pharm vs Avita: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Avita (4735) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Avita

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYAvitaYoY
Oct 2026NT$2.13 billion-22.5%NT$105.1 million+61.5%
Sep 2026NT$2.77 billion+128.0%NT$100.8 million+37.0%
Aug 2026NT$2.11 billion+81.7%NT$102 million+23.6%
Jul 2026NT$2.49 billion+3.9%NT$114.8 million+43.1%
Jun 2026NT$3.4 billion+225.5%NT$82.1 million-14.9%
May 2026NT$2.32 billion+105.8%NT$84.1 million+3.0%
Apr 2026NT$3.09 billion+19.9%NT$107.7 million+43.7%
Mar 2026NT$4.35 billion+173.6%NT$102.3 million+17.4%
Feb 2026NT$2.24 billion+131.5%NT$51.2 million+22.7%
Jan 2026NT$2.05 billion-5.5%NT$60.6 million-13.1%
Dec 2025NT$2.44 billion+66.9%NT$104.7 million+55.3%
Nov 2025NT$1.06 billion-0.2%NT$78.8 million-2.8%
Oct 2025NT$2.75 billion+46.0%NT$65.1 million+8.5%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16